Xiamen Skyblue New Energy Technology Co.,Ltd – Trademark Portfolio
Entity Type: 99
Xiamen Skyblue New Energy Technology Co.,Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 12 (Vehicles) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AMPOZEST. The owner is based in Xiamen.
Software Park II, Torch high-tech Zone
Xiamen 361008 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xiamen Skyblue New Energy Technology Co.,Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Xiamen Skyblue New Energy Technology Co.,Ltd have?
Xiamen Skyblue New Energy Technology Co.,Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Xiamen Skyblue New Energy Technology Co.,Ltd file in?
Xiamen Skyblue New Energy Technology Co.,Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 12 (Vehicles). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Xiamen Skyblue New Energy Technology Co.,Ltd's most well-known trademarks?
Xiamen Skyblue New Energy Technology Co.,Ltd's registered trademark portfolio includes well-known marks such as AMPOZEST. These are among 2 currently registered trademarks in the portfolio.
What is Xiamen Skyblue New Energy Technology Co.,Ltd's trademark registration success rate?
Xiamen Skyblue New Energy Technology Co.,Ltd has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.